VCM
MDXG icon

Versant Capital Management’s MiMedx Group MDXG Stock Holding History

Versant Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-200
Closed -$790 – 2815
2026
Q1 		$790 Sell
200
-637
-76% -$3.21K ﹤0.01% 2681
2025
Q4 		$5.67K Buy
837
+634
+312% +$4.44K ﹤0.01% 2209
2025
Q3 		$1.42K Sell
203
-17
-8% -$118 ﹤0.01% 2466
2025
Q2 		$1.34K Buy
220
+17
+8% +$113 ﹤0.01% 2450
2025
Q1 		$1.54K Hold
203
– – ﹤0.01% 2308
2024
Q4 		$1.95K Buy
+203
New +$1.58K ﹤0.01% 2066

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Versant Capital Management's MDXG Position: Q2 2026 in Review

Versant Capital Management sold out of MiMedx Group (MDXG) in Q2 2026, closing a stake of 200 shares — an estimated $790 sold.

Versant Capital Management first reported a position in MDXG in Q4 2024 and held it in 6 quarters. The position peaked at $5.67K in Q4 2025. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Versant Capital Management reported no remaining MiMedx Group position as of Q2 2026 after selling out during the quarter.
  • Versant Capital Management sold 200 MiMedx Group shares in Q2 2026, an estimated $790.
  • Versant Capital Management first reported a position in MiMedx Group in Q4 2024 and held it in 6 quarters.
  • Versant Capital Management's MiMedx Group position peaked at $5.67K in Q4 2025.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.